Cornerstone Capital Management Holdings LLC. decreased its holdings in Zoetis Inc. (NYSE:ZTS) by 0.3% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 84,960 shares of the company’s stock after selling 262 shares during the quarter. Cornerstone Capital Management Holdings LLC.’s holdings in Zoetis were worth $5,298,000 as of its most recent filing with the SEC.
Several other hedge funds have also made changes to their positions in ZTS. Northwestern Mutual Wealth Management Co. raised its stake in shares of Zoetis by 16.8% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock valued at $100,000 after buying an additional 230 shares in the last quarter. Guardian Life Insurance Co. of America raised its stake in shares of Zoetis by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,905 shares of the company’s stock valued at $102,000 after buying an additional 13 shares in the last quarter. Point72 Asia Hong Kong Ltd acquired a new position in shares of Zoetis in the 1st quarter valued at $111,000. Harfst & Associates Inc. raised its stake in shares of Zoetis by 16.1% in the 2nd quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock valued at $117,000 after buying an additional 260 shares in the last quarter. Finally, Almanack Investment Partners LLC. acquired a new position in shares of Zoetis in the 2nd quarter valued at $119,000. Institutional investors own 93.20% of the company’s stock.
WARNING: This report was reported by Markets Daily and is the property of of Markets Daily. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.themarketsdaily.com/2017/10/12/cornerstone-capital-management-holdings-llc-sells-262-shares-of-zoetis-inc-zts.html.
ZTS has been the subject of a number of recent research reports. Cantor Fitzgerald set a $75.00 price objective on shares of Zoetis and gave the company a “buy” rating in a research note on Monday, August 14th. Stifel Nicolaus restated a “buy” rating and issued a $65.00 price objective on shares of Zoetis in a research note on Friday, September 1st. Deutsche Bank AG restated a “buy” rating and issued a $65.00 price objective (up previously from $62.00) on shares of Zoetis in a research note on Monday, July 17th. BidaskClub cut shares of Zoetis from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, September 20th. Finally, Cowen and Company set a $60.00 price objective on shares of Zoetis and gave the company a “buy” rating in a research note on Tuesday, July 11th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Zoetis currently has a consensus rating of “Buy” and a consensus price target of $65.44.
Shares of Zoetis Inc. (NYSE:ZTS) opened at 64.32 on Thursday. Zoetis Inc. has a 52-week low of $46.86 and a 52-week high of $65.83. The firm has a market cap of $31.46 billion, a PE ratio of 36.36 and a beta of 1.02. The firm has a 50-day moving average of $63.65 and a 200 day moving average of $60.76.
Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, August 8th. The company reported $0.53 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.53. The firm had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. Zoetis had a return on equity of 62.49% and a net margin of 17.50%. The business’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.49 earnings per share. On average, equities analysts predict that Zoetis Inc. will post $2.34 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 1st. Shareholders of record on Thursday, November 9th will be paid a dividend of $0.105 per share. This represents a $0.42 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend is Wednesday, November 8th. Zoetis’s payout ratio is 23.73%.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.